Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists

The synthesis and structure-activity relationships for a series of substituted 4,5-diphenylimidazole-2-carboxamide derivatives 2b as selective, orally active human CB1 inverse agonists are described.